Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:06

Coagulation

1.3K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.3K
Coagulation01:09

Coagulation

9.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.8K
Decreasing Function01:27

Decreasing Function

243
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
243
Decreased Body Temperature01:29

Decreased Body Temperature

1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Decreased pulse rate01:14

Decreased pulse rate

861
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
861
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.1K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral tetrahydrobiopterin is involved in the pathogenesis of mechanical hypersensitivity in a rodent postsurgical pain model.

Pain·2020
Same author

Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.

European journal of pharmacology·2020
Same author

Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling.

Scientific reports·2020
Same author

Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, After Subarachnoid Hemorrhage.

Journal of pharmacological sciences·2020
Same author

Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2018
Same author

Synaptic weight set by Munc13-1 supramolecular assemblies.

Nature neuroscience·2017

Related Experiment Video

Updated: Jan 24, 2026

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.2K

Thrombomodulin alfa prevents the decrease in platelet aggregation in rat models of disseminated intravascular

Naoya Kimpara1, Shunsuke Tawara1, Koh Kawasaki1

  • 1Laboratory for Pharmacology, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan.

Thrombosis Research
|May 17, 2019
PubMed
Summary

Thrombomodulin alfa (TM alfa) improved platelet aggregation in rat models of disseminated intravascular coagulation (DIC). This suggests TM alfa may help restore platelet function in DIC patients by influencing plasma composition.

Keywords:
Disseminated intravascular coagulationPlatelet aggregationPlatelet transfusionThrombomodulinThromboplastin

More Related Videos

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.4K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.6K

Related Experiment Videos

Last Updated: Jan 24, 2026

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.2K
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.4K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.6K

Area of Science:

  • Hematology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Disseminated intravascular coagulation (DIC) is a life-threatening condition marked by excessive blood clotting, leading to reduced platelet counts and impaired platelet aggregation.
  • Thrombomodulin alfa (TM alfa), a soluble form of thrombomodulin, is known to mitigate hypercoagulation in DIC patients.
  • The specific impact of TM alfa on the platelet aggregation defects observed in DIC requires further investigation.

Purpose of the Study:

  • To investigate the therapeutic effects of Thrombomodulin alfa (TM alfa) on impaired platelet aggregation in rat models of disseminated intravascular coagulation (DIC).
  • To elucidate the role of plasma composition versus platelet function in TF-induced DIC-related platelet aggregation impairment.

Main Methods:

  • Disseminated intravascular coagulation (DIC) was induced in Sprague-Dawley rats using lipopolysaccharide (LPS) or tissue factor (TF) administration, with or without concurrent TM alfa treatment.
  • Platelet aggregation was measured ex vivo using collagen or adenosine diphosphate (ADP) as agonists in platelet-rich plasma.
  • Experiments involving platelet-rich plasma, washed platelets, and platelet transfusions were conducted to differentiate between plasma and platelet-intrinsic effects.

Main Results:

  • TM alfa demonstrated a dose-dependent inhibition of the decrease in platelet aggregation observed in both LPS- and TF-induced DIC rat models.
  • While washed platelet aggregation remained unaffected in TF-induced DIC, plasma from these rats impaired normal platelet aggregation, indicating a role for plasma factors.
  • Platelet transfusions in TF-treated rats increased platelet count but did not restore platelet aggregation, further supporting the contribution of plasma composition changes.

Conclusions:

  • Thrombomodulin alfa (TM alfa) effectively attenuated the impairment of platelet aggregation in lipopolysaccharide (LPS)- and tissue factor (TF)-induced disseminated intravascular coagulation (DIC) rat models.
  • The findings suggest that alterations in plasma composition significantly contribute to the reduced platelet aggregation observed in TF-induced DIC.
  • TM alfa's ability to improve platelet aggregation may be linked to its effects on plasma factors involved in the DIC process.